V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212080 | 20167799 | 1.8 | 81 | Adjuvant (A) | 2021-12-22 | 2022-01-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100503967 |
| 20212082 | 20167800 | 1.63 | 108 | Palliative (P) | 2019-06-17 | 2019-06-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100467371 |
| 20212103 | 20167801 | 1.75 | 121.95 | 02 | 2022-01-08 | 2022-02-17 | CETUXIMAB | 02 | Y | CETUXIMAB | 101114452 |
| 20212106 | 20167802 | 1.76 | 60.2 | Palliative (P) | 2017-02-27 | 2017-05-27 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100604540 |
| 20212108 | 20167803 | 1.61 | 82.7 | Palliative (P) | 2018-07-26 | 2018-08-17 | Trastuzumab | 02 | N | TRASTUZUMAB | 100352970 |
| 20212116 | 20167804 | 1.7 | 111 | null | 2017-02-19 | 2017-03-26 | Cetuximab 14 day | null | null | CAPECITABINE + CISPLATIN | 100627340 |
| 20212124 | 20167805 | 1.82 | 60.65 | null | 2021-11-07 | 2021-11-22 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101574246 |
| 20212126 | 20167806 | 1.87 | 98 | null | null | 2020-07-09 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101386554 |
| 20212127 | 20167807 | 1.81 | 117.5 | Curative (C) | 2016-12-16 | 2016-12-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100531517 |
| 20212128 | 20167808 | 1.65 | 84 | Palliative (P) | 2020-06-17 | 2020-07-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101798688 |
| 20212129 | 20167809 | 1.65 | 94.3 | Palliative (P) | 2018-08-01 | 2018-08-26 | CETUXIMAB | 02 | N | CETUXIMAB | 100195871 |
| 20212135 | 20167810 | 1.8 | 56.7 | null | 2021-02-20 | 2021-03-03 | CETUXIMAB | 02 | null | CETUXIMAB | 100936534 |
| 20212143 | 20167811 | 1.61 | 67.5 | null | 2019-03-25 | 2019-04-02 | TRASTUZUMAB | 02 | N | CETUXIMAB | 100875807 |
| 20212144 | 20167812 | 1.78 | 59.8 | Palliative (P) | 2021-04-17 | 2021-04-17 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100674751 |
| 20212145 | 20167813 | 1.53 | 74.4 | Palliative (P) | null | 2018-07-23 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101475422 |
| 20212148 | 20167814 | 1.81 | 76.6 | null | 2017-02-28 | 2018-03-22 | CETUXIMAB | 02 | null | CETUXIMAB | 101389036 |
| 20212150 | 20167815 | 1.75 | 82.4 | Palliative (P) | 2018-10-13 | 2018-11-18 | CETUXIMAB | 02 | N | CETUXIMAB | 100599325 |
| 20212162 | 20167816 | 1.77 | 38 | null | 2018-07-22 | 2018-07-30 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100304192 |
| 20212163 | 20167817 | 1.78 | 83.5 | Curative (C) | 2019-10-13 | 2019-11-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 100981133 |
| 20212166 | 20167819 | 1.59 | 99.35 | Neo-adjuvant (N) | 2018-04-06 | 2018-06-08 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100807243 |
| 20212167 | 20167820 | 1.7 | 107.6 | Adjuvant (A) | 2018-11-25 | 2018-11-25 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101006412 |
| 20212170 | 20167821 | 1.49 | 58.1 | Curative (C) | 2021-11-25 | 2021-11-25 | CETUXIMAB | 02 | N | CETUXIMAB | 100411649 |
| 20212176 | 20167822 | 1.53 | 87.5 | Palliative (P) | 2018-12-06 | 2018-12-09 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100785556 |
| 20212185 | 20167823 | 1.84 | 81 | Palliative (P) | 2019-12-17 | 2019-12-21 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100445216 |
| 20212186 | 20167824 | 1.81 | 70 | Adjuvant (A) | 2018-03-14 | 2018-03-17 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101269498 |
| 20212190 | 20167825 | 1.74 | 77.2 | Palliative (P) | 2020-05-21 | 2020-06-05 | CETUXIMAB | 99 | N | CAPECITABINE + CISPLATIN | 100065718 |
| 20212191 | 20167826 | 1.88 | 75.3 | null | 2016-03-28 | 2016-06-25 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100990268 |
| 20212204 | 20167827 | 1.7 | 61 | Adjuvant (A) | 2017-12-19 | 2018-01-09 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101119606 |
| 20212207 | 20167828 | 1.63 | 71 | Adjuvant (A) | 2016-10-30 | 2016-11-28 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100585277 |
| 20212218 | 20167830 | 1.62 | 90 | null | 2016-08-04 | 2016-10-26 | CETUXIMAB | 02 | null | CETUXIMAB | 100013972 |
| 20212223 | 20167831 | 0 | 82.6 | null | 2018-12-02 | 2019-01-11 | CETUXIMAB | 02 | null | TRASTUZUMAB | 101586305 |
| 20212230 | 20167832 | 1.62 | 85 | Palliative (P) | 2017-01-28 | 2017-02-16 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100313822 |
| 20212237 | 20167833 | 1.61 | 77.6 | Palliative (P) | 2020-11-27 | 2020-12-01 | Trastuzumab | 02 | N | TRASTUZUMAB | 101733458 |
| 20212238 | 20167834 | 1.73 | 56.6 | Adjuvant (A) | 2017-08-15 | 2017-08-20 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100358011 |
| 20212246 | 20167835 | 1.81 | 87.5 | Palliative (P) | 2020-03-09 | 2020-03-10 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101227608 |
| 20212248 | 20167836 | 1.8 | 75 | Palliative (P) | 2020-10-31 | 2020-11-07 | CETUXIMAB | 02 | N | CETUXIMAB | 101302826 |
| 20212257 | 20167837 | 1.81 | 75 | Adjuvant (A) | 2019-11-30 | 2020-02-07 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100092045 |
| 20212262 | 20167838 | 1.49 | 78.5 | Palliative (P) | 2017-11-17 | 2018-02-18 | CETUXIMAB | 02 | N | CETUXIMAB | 100124589 |
| 20212266 | 20167839 | 1.51 | 38 | null | 2020-11-25 | 2021-07-14 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100915023 |
| 20212268 | 20167840 | 1.59 | 63.55 | Palliative (P) | null | 2019-03-07 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100335970 |
| 20212270 | 20167841 | null | null | Palliative (P) | 2016-05-22 | 2016-07-14 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101495003 |
| 20212273 | 20167842 | 1.76 | 80.6 | Curative (C) | 2020-01-28 | 2020-06-14 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100213554 |
| 20212281 | 20167843 | 1.76 | 62 | Palliative (P) | 2021-08-19 | 2021-10-02 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100292518 |
| 20212289 | 20167844 | 1.72 | 75 | null | 2016-05-21 | 2016-09-21 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100277136 |
| 20212291 | 20167845 | null | null | Palliative (P) | 2021-05-04 | 2021-05-04 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101774599 |
| 20212302 | 20167846 | 1.57 | 80.9 | null | 2019-10-11 | 2019-10-23 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 100519828 |
| 20212305 | 20167847 | 1.74 | 46.5 | Curative (C) | 2018-01-23 | 2018-01-30 | Trastuzumab | 02 | null | TRASTUZUMAB | 101272450 |
| 20212308 | 20167848 | 1.7 | 93 | Palliative (P) | 2018-02-09 | 2018-03-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 101438679 |
| 20212310 | 20167849 | 1.66 | 113 | Palliative (P) | 2021-08-19 | 2021-08-20 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101273272 |
| 20212311 | 20167850 | 1.8 | 102 | Palliative (P) | 2021-07-20 | 2021-08-12 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101666104 |